| INTRODUCTION
Conservative management of both abnormally adherent (placenta creta) and invasive placenta (placenta increta and percreta) defines all procedures that aim to avoid peripartum hysterectomy and its related morbidity and consequences. Four different primary methods of conservative management have been described in the international literature: (1) the extirpative technique (manual removal of the placenta); (2) leaving the placenta in situ or the expectant approach; (3) one-step conservative surgery (removal of the accreta area); and (4) the Triple-P procedure (suturing around the accreta area after resection). These methods have been used alone or in combination and in many cases with additional procedures such as those proposed by interventional radiology.
The main aim of leaving the placenta in situ versus the extirpative method is essentially to attempt to decrease the risks of severe maternal morbidity during cesarean delivery. [1] [2] [3] [4] Forcibly removing an invasive placenta-with placental villi that have invaded the deep uterine vasculature 5 -increases the risks of massive obstetric hemorrhage and the need for salvation hysterectomy. Uncontrolled bleeding will lead to coagulopathy and will also complicate the surgical procedure, increasing the risk of injuries mainly to the bladder and ureters and their possible long-term complications such as vesicouterine fistula.
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Successful conservative management strategies will also preserve fertility and thus reduce the impact on a woman's societal status and self-esteem associated with the loss of her uterus.
The purpose of this chapter is to assist obstetrician-gynecologists in selecting the most appropriate conservative treatment option to manage women with the different types of placenta accreta spectrum (PAS) disorders according to their individual need and the local expertise of the healthcare team. Since histopathological confirmation of adherent or invasive placentation is rarely available in most cases of conservative management and few authors provide detailed clinical information on the differential diagnosis between retained placenta and abnormally adherent placenta or the depth and lateral extension of accreta placentation, we use the term PAS disorders to describe both adherent and invasive placentation. When available we refer to the different depth of PAS disorders, i.e. creta, increta, and percreta.
| THE EXTIRPATIVE TECHNIQUE
This procedure consists of forcibly removing the placenta manually in an attempt to empty the uterus at delivery. The aim of this approach is to avoid leaving retained placental tissues in the uterine cavity and it is recommended by established worldwide guidelines as one of the first steps to manage postpartum hemorrhage. [6] [7] [8] [9] [10] [11] [12] [13] However, in cases of PAS disorders, this procedure often results in massive obstetric hemorrhage and, overall, not disturbing the accreta portion of the placenta is associated with more than a 50% reduction in blood loss and need for transfusions.
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A retrospective study comparing two consecutive periods of PAS disorder management in a single center found a reduction in the mean amount of red blood cells transfused, disseminated intravascular coagulation, hysterectomy rates, and secondary maternal infection during the second period when the placenta was left in situ compared with the first period when the placenta was always removed manually.
14 PAS disorders were diagnosed in the 51 cases included in this study using the following clinical criteria:
1. Manual removal of the placenta partially or totally impossible and with no cleavage plane between all or part of the placenta and uterus.
2. Prenatal diagnosis of accreta placentation, confirmed by the failure of gentle attempts to remove it during the third stage of labor.
3. Evidence of invasive placental tissue at the time of surgery.
Histologic confirmation of PAS disorders on a hysterectomy
specimen.
Overall, most experts in the management of PAS disorders consider that attempts at manual removal of the placenta should be avoided in cases of planned cesarean hysterectomy. [15] [16] [17] [18] [19] [20] [21] In women presenting with risk factors for abnormally invasive placenta (placenta previa and multiple prior cesarean deliveries) but no suspicion of PAS disorders on prenatal ultrasound (false-negative), surgeons performing the cesarean delivery should not attempt to manually remove the placenta when the clinical signs suggest PAS disorders and/or there are unusual or unexplained difficulties at delivering the placenta. Within this context, new epidemiological data are needed to better evaluate the numbers of false-negative and false-positive cases of PAS disorders in the general obstetric population. In particular, there is a need for data that differentiate between adherent and invasive PAS.
| "LEAVING THE PLACENTA IN SITU" APPROACH
This approach consists of leaving the placenta in situ and waiting for its complete spontaneous resorption. It was initially called the "conservative treatment of placenta accreta". 19 As other conservative approaches have since been described, it is more accurate to use the terms "leaving the placenta in situ approach" or "expectant management". 20 This approach is based on the following evidence-based clinical concepts [18] [19] [20] [21] :
1. Cesarean hysterectomy is considered the gold standard treatment for invasive accreta but it remains associated with high rates (40%-50%) of severe maternal morbidity and, in cases of placenta percreta, the mortality rates can be as high as 7% owing to damage to pelvic organs and vasculature.
2. The extirpative method is associated with severe maternal morbidity because it leaves, within the myometrium, placental tissues connected to large feeding vessels, which are responsible for uncontrolled massive obstetric hemorrhage.
By leaving a placenta accreta in situ after the delivery of the fetus, one can expect a progressive decrease in blood circulation within the uterus, parametrium, and the placenta. This will result in secondary necrosis of the villous tissue and theoretically the placenta should progressively detach itself from the uterus and the percreta villi from the adjacent pelvic organs. 
| Practical issues
In cases of invasive PAS disorders diagnosed prenatally, the exact position of the placenta should be determined by preoperative ultra- Failure to do so suggests the diagnosis of a PAS disorder and in these cases, the cord should be cut close to its placental insertion and the uterine cavity should be closed. Postoperative antibiotic therapy is usually administered prophylactically to minimize the risk of infection.
A literature review performed up to 2007, including 48 case reports describing the outcome of 60 women presenting with PAS disorders and managed by leaving the placenta in situ, found that of the 26 women managed without the use of additional therapies, 22
(85%) had a favorable outcome. 24 Expectant management failed in 4 (15%) cases and secondary hysterectomy had to be performed owing to massive obstetric hemorrhage or infection.
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A French multicenter retrospective study of 167 cases of PAS disorders managed in 40 teaching hospitals evaluated the maternal outcome after conservative treatment and found that 25 (63%) of the centers reported to have used conservative treatment for PAS disorders at least once. 2 Conservative management in cases of PAS disorders was defined by the decision of the obstetrician to leave the placenta partially or totally in situ, with no attempt to remove it forcibly. In 59% of the cases the placenta was left partially in situ and in 41% it was left completely in situ ( Table 1) . The overall success rate of uterine preservation was 78% (95% CI, 71%-84%) and severe maternal morbidity including sepsis, septic shock, peritonitis, uterine necrosis, postpartum uterine rupture, fistula, injury to adjacent organs, acute pulmonary edema, acute renal failure, deep vein thrombophlebitis or pulmonary embolism, or maternal death was reported in 10 (6%) cases. 2 There was one maternal death due to multiorgan failure and septic shock, following the additional injection of methotrexate in the umbilical cord. Other rare morbidities including fistula and arteriovenous fistula formation were also reported in this series and by other authors. [25] [26] [27] An empty uterus was obtained spontaneously in 75% of cases after a median of 13.5 weeks (range, 4-60 weeks). 2 The results of this large study suggest that it is possible for centers with limited experience in conservative treatment of PAS disorders to attempt to preserve the uterus by leaving the placenta in situ, but it is essential that these centers have emergency access to blood products, obstetric anesthesia, interventional radiology, urology, and gynecological oncology expertise. The lack of data on the depth of villous invasion in most the cases included in this study does not allow the standardization of the management approach.
There are limited data on the conservative management of placenta percreta. A small series of three cases of placenta percreta and review of 57 cases from the literature found that when managed conservatively with the placenta left in situ, hysterectomy can be avoided in 60% of cases. 28 However, 42% of these cases had major complications including sepsis, coagulopathy, hemorrhage, pulmonary embolism, fistula, and arteriovenous malformation. In another review, in 36 cases of placenta percreta managed by leaving the placenta in situ, delayed secondary hysterectomy was required in 58% of cases. 27 In the French national study, there were 18 cases of placenta percreta where the placenta was left in situ. 2 Conservative treatment was successful in 10 (55.6%) cases but severe maternal morbidity was observed in 3 (16.7%) cases. Of the eight cases of placenta percreta with bladder involvement, conservative treatment was successful in 6 (75%) cases but severe maternal morbidity occurred in 2 (25%) cases. Overall, these data suggest that leaving the placenta in situ may be an option for women who desire to preserve their fertility and agree to close follow-up in centers with adequate expertise.
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| Additional procedures
Additional procedures (i.e. embolization or vessel ligation, temporal internal iliac balloon occlusion, methotrexate, hysteroscopic resection of retained tissues) have been used in a conservative approach with the placenta left in situ to decrease morbidity or to accelerate placental resorption. 19 There are no randomized controlled trials comparing T A B L E 1 Maternal morbidity after conservative treatment for placenta accreta spectrum (PAS) disorders. these different additional procedures and the quality of the evidence varies according to the type of procedure used.
| Gentle attempted removal of the placenta
In case of false-positive prenatal diagnosis with no clinical evidence of PAS disorders at cesarean delivery, gentle attempted removal of the placenta can be tried. In cases of PAS disorders visibly limited to a small portion of the uterine wall, it is sometimes possible to remove the "non-accreta" portion of the placenta, thus reducing the volume of villous tissue left in situ. 19 Overall, the main risk of this strategy is the risk of massive obstetric hemorrhage and the need for emergent hysterectomy if the placenta is accreta; thus, this can only be attempted if a multidisciplinary team is available for an emergent hysterectomy. In women with a placenta in situ who are successfully treated with methotrexate, the beta-human chorionic gonadotropin (β-hCG) levels and Doppler vascular resistance indices of the uteroplacental arterial circulation decrease faster than in those with treatment failure. 30 An earlier systematic review of different uterus preserving treatment modalities in 16 women with PAS disorders found that methotrexate therapy is associated with a low rate (6%) of secondary hysterectomy, although the number of cases reviewed was low. 32 The authors also reported subsequent menstruation in four out of five cases (80%) and a subsequent pregnancy in one out of two cases (50%). 32 One case of maternal death was reported in the French national survey 2 and disseminated intravascular coagulation may develop requiring a secondary hysterectomy. 33 Overall, the use of methotrexate is not recommended until further evidence is available on its efficacy and safety.
| Methotrexate adjuvant treatment

| Preventive surgical or radiological uterine devascularization
There are also very limited data on the use of these adjuvant techniques. [34] [35] [36] [37] [38] [39] [40] [41] [42] [43] [44] Preventive devascularization can be achieved by surgical or interventional radiology procedures also used in the management of severe postpartum hemorrhage, such as stepwise uterine surgical devascularization, bilateral uterine or hypogastric artery surgical ligation, iliac artery embolization, or balloon occlusion. Embolization before performing hysterectomy may reduce the risk of intraoperative blood loss 36 and prophylactic devascularization may prevent the occurrence of secondary hemorrhage 37 and could also accelerate placental resorption. 38 Overall, these uterine-sparing procedures seem to be less effective in cases of PAS disorders.
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A systematic review including 177 cases of PAS disorders reported success rates of 90% for arterial embolization, with secondary hysterectomy necessary in only 11.3%. 39 In the remaining 85 women, subsequent menstruation occurred in 87% and three women had a subsequent pregnancy. The indications for embolization and the depth of villous invasion are not accurately reported by the authors, limiting the interpretation of the data. This technique is also associated with significant maternal morbidity.
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The value of prophylactic placement of balloon catheters in the iliac arteries in cases of PAS disorders is even more controversial, mainly owing to the higher risks of complications than with embolization. In particular, there are two case reports, one of a popliteal and one of an external iliac arterial thrombus, 40,41 a case of iliac artery rupture, 42 and a case of ischemic nerve injury attributable to iliac artery thrombosis complicating common iliac balloon catheterization at cesarean hysterectomy.
A recent single-institution observational cohort series of 45 cases of PAS disorders reported the use of prophylactic lower abdominal aorta balloon occlusion and found a reduced need for blood transfusion. 43 One of the cases was complicated by lower extremity arterial thrombosis and another by ischemic injury to the femoral nerve. A small randomized controlled trial of women presenting with a prenatal diagnosis of PAS disorders was recently published. 44 Women were randomized to either preoperative prophylactic balloon catheters (n=13)
or to a control group (n=14). No difference was observed for the number of women with blood loss greater than 2500 mL, number of plasma products transfused, duration of surgery, peripartum complications, and hospitalization length. Reversible adverse effects related to prophylactic balloon catheter insertion were observed in 2 of 13 (15.4%) cases (leg pain and weakness without swelling in one case and buttock claudication and abdominal pain in the other). 44 Larger studies and randomized controlled trials are essential to demonstrate the safety and efficacy of prophylactic bilateral iliac balloon occlusion before this technique can be offered in the management of PAS disorders.
| Systematic hysteroscopic resection of retained accreta tissue
In a small series of 23 women with PAS disorders with the placenta left in situ, 12 hysteroscopies were performed under ultrasound guidance owing to pain and/or bleeding with retained tissues. 45 The use of bipolar energy was limited to avoid any potential uterine perforation.
The median size of the retained placenta was 54 mm (13-110 mm). 
| Monitoring of leaving the placenta in situ approach
The pattern of follow-up after leaving the placenta in situ in cases of PAS disorders is not supported by randomized controlled trials. The residual villous tissue in the uterine wall may require up to 6 months to be completely absorbed. 31 In rare cases, a coagulopathy or septicemia may develop, requiring an emergent secondary hysterectomy.
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Measuring serum β-hCG on a weekly basis to check it falls continuously can reassure to some extent, but low levels do not guarantee complete placental resorption and so this should be supplemented by expert ultrasound imaging. There is insufficient evidence to recommend the use of MRI. 
| Long-term obstetric and fertility outcomes
Successful conservative treatment for PAS disorders does not appear to compromise subsequent fertility or obstetric outcome, but data are limited. Pregnancies following prior PAS disorders are at increased risk for adverse maternal outcomes including recurrent PAS disorders, uterine rupture, postpartum hemorrhage, and peripartum hysterectomy. [47] [48] [49] Overall, the risk of recurrence of PAS disorders ranges between 22% 50 and 29%, 49 whereas the risk of early postpartum hemorrhage ranges between 8.6% 50 and 19%. 49 Long-term complications also include intrauterine adhesions and secondary amenorrhea, 49 which both have a direct effect on fertility.
All women included in the French national retrospective study who did not undergo a hysterectomy were contacted to evaluate their fertility and pregnancy outcomes after successful expectant management. 49 Follow-up data were available for 96 of the 131 women (73.3%) included in the study. Eight (8.3%) women had severe intrauterine adhesions and were amenorrheic. Of the 27 women who wanted more children, 24 (88.9%) women had 34 pregnancies with a mean time to conception of 17.3 months (range, 2-48 months). All 21 deliveries resulted in healthy babies born after 34 weeks of gestation.
PAS disorders recurred in 6 of 21 cases (28.6%) and were associated with placenta previa in four cases. Postpartum hemorrhage occurred in 4 (19%) cases, related to accreta placentation in three and to uterine atony in one. These results indicate that pregnancy is possible in most cases of successful conservative management, but is associated with an almost 30% risk of PAS disorders in subsequent pregnancies.
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| ALTERNATIVE CONSERVATIVE SURGICAL PROCEDURES
| One-step conservative surgery
This surgical procedure has been described primarily by one author. Triple-P procedure group. 4 Larger studies are needed to demonstrate the safety and efficacy of this technique.
| Tamponade techniques
Small case series have also reported the successful use of compres- 
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T A B L E 2 Recommendations for conservative management of placenta accreta spectrum (PAS) disorders.
Recommendations
Resource settings
Quality of evidence and strength of recommendation
Leaving the placenta in situ is an option for women who desire to preserve their fertility and agree to continuous long-term monitoring in centers with adequate expertise
High
Moderate and Strong
The extirpative approach or forcible manual removal of the placenta should be abandoned All High and Strong
When a conservative treatment is attempted in cases of PAS disorders diagnosed prenatally, the exact position of the placenta should be confirmed by a preoperative ultrasound and the equipment and expert surgical team should be on stand-by for an emergent hysterectomy
High
Moderate and Strong
After the delivery of the fetus, and only in cases with no clinical evidence of invasive PAS disorders, the surgeon may carefully attempt to remove the placenta by controlled cord traction and the use of uterotonics
All
Low and Strong
Postoperative antibiotic therapy (amoxicillin and clavulanic acid or clindamycin in case of penicillin allergy) should be administered prophylactically to minimize the risk of infection when the placenta is left in situ High Low and Weak
The use of methotrexate is not recommended until further evidence is available on its efficacy and safety High Moderate and Strong
Preventive surgical or radiological uterine devascularization is not recommended routinely High Low and Weak
There is insufficient evidence to recommend the use of magnetic resonance imaging and/or measuring serum β-hCG for the monitoring of conservative management cases
High Low and Weak
Women who want another pregnancy should be advised that the recurrence risk of PAS disorders is high All High and Strong
The one-step conservative surgery is less reproducible than other conservative management approaches, mainly because the efficacy of hemostasis is operator dependent High Low and Weak
